Abbott Total Assets from 2010 to 2026

ABL Stock  EUR 93.71  1.96  2.05%   
Abbott Laboratories' Total Assets are increasing over the last several years with slightly volatile swings. Total Assets are predicted to flatten to about 72.3 B. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2016-12-31
Previous Quarter
84 B
Current Value
84.2 B
Quarterly Volatility
5.5 B
 
Covid
 
Interest Hikes
Check Abbott Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abbott Laboratories' main balance sheet or income statement drivers, such as Discontinued Operations of 20.5 M, Interest Expense of 414.6 M or Selling General Administrative of 10.3 B, as well as many indicators such as . Abbott financial statements analysis is a perfect complement when working with Abbott Laboratories Valuation or Volatility modules.
  
This module can also supplement various Abbott Laboratories Technical models . Check out the analysis of Abbott Laboratories Correlation against competitors.
For more detail on how to invest in Abbott Stock please use our How to Invest in Abbott Laboratories guide.
The Total Assets trend for Abbott Laboratories offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Abbott Laboratories is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Abbott Laboratories' Total Assets Growth Pattern

Below is the plot of the Total Assets of Abbott Laboratories over the last few years. Total assets refers to the total amount of Abbott Laboratories assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Abbott Laboratories books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Abbott Laboratories' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Abbott Laboratories' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 81.41 B10 Years Trend
Slightly volatile
   Total Assets   
       Timeline  

Abbott Total Assets Regression Statistics

Arithmetic Mean62,001,064,706
Geometric Mean59,506,431,147
Coefficient Of Variation28.49
Mean Deviation15,771,700,346
Median67,887,000,000
Standard Deviation17,666,325,527
Sample Variance312099057.6T
Range52.4B
R-Value0.90
Mean Square Error63803229.1T
R-Squared0.81
Slope3,145,388,971
Total Sum of Squares4993584921.9T

Abbott Total Assets History

202672.3 B
202593.6 B
202481.4 B
202373.2 B
202274.4 B
202175.2 B
202072.5 B

About Abbott Laboratories Financial Statements

Abbott Laboratories stakeholders use historical fundamental indicators, such as Abbott Laboratories' Total Assets, to determine how well the company is positioned to perform in the future. Although Abbott Laboratories investors may analyze each financial statement separately, they are all interrelated. For example, changes in Abbott Laboratories' assets and liabilities are reflected in the revenues and expenses on Abbott Laboratories' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Abbott Laboratories. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Assets93.6 B72.3 B

Currently Active Assets on Macroaxis

When determining whether Abbott Laboratories is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Abbott Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Abbott Laboratories Stock. Highlighted below are key reports to facilitate an investment decision about Abbott Laboratories Stock:
Check out the analysis of Abbott Laboratories Correlation against competitors.
For more detail on how to invest in Abbott Stock please use our How to Invest in Abbott Laboratories guide.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Understanding that Abbott Laboratories' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Abbott Laboratories represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Abbott Laboratories' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.